Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4558269
Max Phase: Preclinical
Molecular Formula: C31H35F4N7O8S
Molecular Weight: 627.70
Molecule Type: Unknown
Associated Items:
ID: ALA4558269
Max Phase: Preclinical
Molecular Formula: C31H35F4N7O8S
Molecular Weight: 627.70
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cccc(F)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCN(S(=O)(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)CC1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C29H34FN7O6S.C2HF3O2/c1-36(2)14-6-11-25(38)32-20-7-4-8-21(17-20)44(41,42)37-15-12-19(13-16-37)33-29(40)27-23(18-31-35-27)34-28(39)26-22(30)9-5-10-24(26)43-3;3-2(4,5)1(6)7/h4-11,17-19H,12-16H2,1-3H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b11-6+;
Standard InChI Key: CLKAQFHAOUAOJN-ICSBZGNSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 627.70 | Molecular Weight (Monoisotopic): 627.2275 | AlogP: 2.45 | #Rotatable Bonds: 11 |
Polar Surface Area: 165.83 | Molecular Species: BASE | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.74 | CX Basic pKa: 8.80 | CX LogP: 2.04 | CX LogD: 0.72 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.24 | Np Likeness Score: -1.74 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):